Pathway Diagram
flowchart TD
OPTN["OPTN<br/>(Optineurin)"]
RIPK1["RIPK1<br/>(Receptor Interacting<br/>Protein Kinase 1)"]
Autophagy["Autophagy<br/>Pathway"]
NFkB["NF-kappaB<br/>Signaling"]
Inflammation["Neuroinflammation"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
Parkinson["Parkinson's<br/>Disease"]
Alzheimer["Alzheimer's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]
Dementia["Dementia"]
Neurodegeneration["Neurodegeneration"]
ProteinAggregation["Protein<br/>Aggregation"]
CellDeath["Neuronal<br/>Cell Death"]
MotorNeuronLoss["Motor Neuron<br/>Degeneration"]
OPTN -->|"inhibits"| RIPK1
OPTN -->|"regulates"| Autophagy
OPTN -->|"inhibits"| NFkB
OPTN -->|"regulates"| Inflammation
RIPK1 -->|"promotes"| NFkB
NFkB -->|"activates"| Inflammation
Inflammation -->|"leads to"| CellDeath
OPTN -->|"mutations cause"| ALS
OPTN -->|"associated with"| Parkinson
OPTN -->|"associated with"| Alzheimer
OPTN -->|"associated with"| MS
OPTN -->|"associated with"| Dementia
ALS -->|"characterized by"| MotorNeuronLoss
Autophagy -->|"clears"| ProteinAggregation
ProteinAggregation -->|"promotes"| Neurodegeneration
CellDeath -->|"leads to"| Neurodegeneration
style OPTN fill:#006494
style Autophagy fill:#1b5e20
style RIPK1 fill:#4a1a6b
style NFkB fill:#4a1a6b
style Inflammation fill:#ef5350
style ALS fill:#5d4400
style Parkinson fill:#5d4400
style Alzheimer fill:#5d4400
style MS fill:#5d4400
style Dementia fill:#5d4400
style Neurodegeneration fill:#ef5350
style ProteinAggregation fill:#ef5350
style CellDeath fill:#ef5350
style MotorNeuronLoss fill:#ef5350| OPTN — Optineurin | |
|---|---|
| Symbol | OPTN |
| Full Name | Optineurin |
| Chromosome | 10p13 |
| NCBI Gene | 10133 |
| Ensembl | ENSG00000123240 |
| OMIM | 602432 |
| UniProt | Q96CV9 |
| Diseases | [ALS](/diseases/als), [Parkinson's disease](/diseases/parkinsons-disease), Glaucoma |
| Expression | Motor cortex, Spinal cord, Retina, Brain |
| Key Mutations | |
| E478G, Q398X, D474N, M98K, 691-692insAG | |
| Associated Diseases | AD, ALI, ALS, ALZHEIMER, ALZHEIMER'S DISEASE |
| KG Connections | 1444 edges |
OPTN — Optineurin
Brain Atlas Resources
Introduction
Optn — Optineurin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
OPTN (Optineurin) is a gene located on chromosome 10p13 that plays a critical role in neurodegenerative disease. Mutations in OPTN are associated with als, parkinson, and glaucoma. The gene is catalogued as NCBI Gene ID 10133 and OMIM 602432.
OPTN encodes a coiled-coil containing protein that functions as a critical adaptor protein involved in multiple cellular processes including autophagy, mitophagy, NF-κB signaling, and Golgi organization. Its role in mitochondrial quality control makes it particularly important for neuronal survival.
Molecular Function
Protein Structure and Binding
OPTN encodes a 577-amino acid protein with multiple functional domains. The protein contains:
-
Coiled-coil domains: Mediate protein-protein interactions
-
Ubiquitin-binding domain (UBD): Enables binding to K63-linked polyubiquitin chains
-
Zinc finger (ZZ) domain: Facilitates zinc ion binding
Key Molecular Functions
-
Polyubiquitin Binding: OPTN binds to K63-linked polyubiquitin chains, enabling recognition of ubiquitinated cargo for selective autophagy1Mutations in the optineurin gene in amyotrophic lateral sclerosisOpen reference.
-
Adaptor Protein Function: OPTN serves as a molecular adaptor linking ubiquitinated proteins to the autophagy machinery through interactions with map1lc3a-protein (microtubule-associated protein 1A/1B-light chain 3)2Optineurin mutations in amyotrophic lateral sclerosis and glaucomaOpen reference.
-
Protein-Protein Interactions: OPTN interacts with:
-
RAB8: Vesicle trafficking and membrane transport
-
Huntingtin: Transcription activation and protein aggregates
-
tbk1: TANK-binding kinase 1 - critical for OPTN phosphorylation and mitophagy activation
-
parkin: E3 ubiquitin ligase in mitophagy pathway
-
Cellular Mechanisms
Mitophagy (Mitochondrial Quality Control)
OPTN is a critical receptor for mitophagy, the selective autophagy of damaged mitochondria. The mechanism involves:
-
Mitochondrial Damage Sensing: Upon mitochondrial damage, proteins on the outer mitochondrial membrane are ubiquitinated by parkin-protein (PINK1-Parkin pathway)3Optineurin regulates mitochondrial dynamics and mitophagyOpen reference.
-
OPTN Recruitment: OPTN binds to ubiquitinated mitochondrial proteins via its ubiquitin-binding domain.
-
TBK1 Activation: Mitochondrial damage activates tbk1-protein, which phosphorylates OPTN at serine 177, enhancing its LC3-binding affinity4TBK1 phosphorylates optineurin and regulates its autophagy receptor functionOpen reference.
-
Autophagosome Formation: Phosphorylated OPTN recruits map1lc3a-protein-positive autophagic membranes to form autophagosomes around damaged mitochondria.
-
Lysosomal Degradation: The autophagosome-lysosome fusion delivers damaged mitochondria for degradation, maintaining neuronal metabolic homeostasis.
NF-κB Signaling Regulation
OPTN negatively regulates canonical nf-kb-signaling, a key pathway in neuroinflammation:
-
OPTN interacts with NF-κB signaling components
-
Loss of OPTN function leads to increased NF-κB activation
-
Dysregulated NF-κB signaling contributes to neuroinflammation in ALS and PD
Golgi Organization
OPTN plays a role in Golgi apparatus organization and protein trafficking:
-
Maintains Golgi ribbon formation
-
Facilitates vesicular transport
-
Disruption affects protein secretion and membrane protein trafficking
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
OPTN mutations cause ALS type 12 (ALS12), accounting for approximately 1-3% of familial ALS cases5Optineurin mutations and glaucoma: molecular mechanismsOpen reference:
-
E478G mutation: Most common pathogenic mutation, located in the ubiquitin-binding domain
-
Q398X nonsense mutation: Produces truncated protein lacking functional domains
-
Deletions: Frameshift mutations causing loss of function
Disease Mechanism:
-
Loss of mitophagy function leads to accumulation of damaged mitochondria
-
Impaired clearance of protein aggregates
-
Increased oxidative stress and neuronal death
-
Some mutations cause both ALS and frontotemporal dementia (FTD)
Parkinson’s Disease
OPTN variants are associated with parkinson:
-
OPTN mutations can cause a PSP (Progressive Supranuclear Palsy)-CBS (Corticobasal Syndrome)-like phenotype
-
Altered mitophagy may contribute to dopaminergic neuron vulnerability
Glaucoma
OPTN was first identified as a glaucoma gene:
-
M98K polymorphism: Associated with normal-tension glaucoma, sensitizes retinal cells to endoplasmic reticulum stress
-
Primary open-angle glaucoma: OPTN variants increase susceptibility
-
Retinal ganglion cell death involves similar mechanisms to neuronal degeneration
Other Associations
-
Paget’s disease of bone: GWAS-identified susceptibility locus
-
Inflammatory diseases: Altered immune response due to NF-κB dysregulation
Therapeutic Implications
Restoring Mitophagy
Therapeutic strategies targeting OPTN-mediated mitophagy:
-
TBK1 Activators: Small molecules enhancing TBK1 activity could improve OPTN phosphorylation
-
Autophagy Enhancers: Compounds promoting autophagy flux (e.g., rapamycin analogs)
-
Gene Therapy: Viral vector delivery of wild-type OPTN
Modulating NF-κB Signaling
-
NF-κB inhibitors: Reduce neuroinflammation in OPTN-deficient neurons
-
Anti-inflammatory approaches: Target microglial activation
TBK1-OPTN Interaction
-
Kinase inhibitors: TBK1 activators to compensate for impaired OPTN function
-
Phosphomimetic approaches: Develop compounds that enhance OPTN-LC3 binding
Research Directions
-
OPTN knockout mouse models show neurodegeneration
-
iPSC-derived neurons from ALS patients with OPTN mutations
-
High-throughput screening for mitophagy-enhancing compounds
Brain Expression
OPTN is expressed in multiple brain regions relevant to neurodegeneration:
-
Motor cortex: Affected in ALS
-
Spinal cord: Site of motor neuron degeneration in ALS
-
Substantia nigra: Dopaminergic neurons affected in PD
-
Retina: Glaucoma relevance
Expression data is available from the Allen Human Brain Atlas.
Key Mutations
| Mutation | Type | Domain | Associated Phenotype |
|---|---|---|---|
| E478G | Missense | UBD | ALS, glaucoma |
| Q398X | Nonsense | Coiled-coil | ALS |
| D474N | Missense | UBD | Glaucoma |
| M98K | Missense | N-terminus | Glaucoma |
| 691-692insAG | Frameshift | C-terminus | ALS |
Key Publications
-
Optineurin is an amyotrophic lateral sclerosis-linked gene. Nature, 2010. PMID: 20228769.
-
OPTN mutations: a new cause of familial ALS. Neuron, 2010. PMID: 21145004.
-
Phosphorylation of optineurin induces autophagy. Autophagy, 2015. PMID: 25879213.
-
OPTN, an autophagy receptor for mitochondrial clearance. Exp Cell Res, 2014. PMID: 24726911.
-
TBK1 controls orchestrated ubiquitination and phosphorylation of OPTN. Cell, 2014. PMID: 25241744.
Background
The study of Optn — Optineurin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
-
Parkinson’s Disease — PD
-
TBK1 — TANK-binding kinase 1
-
Parkin — PRKN
-
PINK1 — PTEN-induced kinase 1
External Links
References
- Mutations in the optineurin gene in amyotrophic lateral sclerosis
- Optineurin mutations in amyotrophic lateral sclerosis and glaucoma
- Optineurin regulates mitochondrial dynamics and mitophagy
- TBK1 phosphorylates optineurin and regulates its autophagy receptor function
- Optineurin mutations and glaucoma: molecular mechanisms
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.